BAYER AKTIENGESELLSCHAFT «12345...» Página 2 de 137 desde 01/07/1988 hasta 03/06/2024 23/09/2019 12:01 BAYER AKTIENGESELLSCHAFT R&D: new licenses, patents and registered trademarks Not intended for U.S. and UK Media - Vitrakvi® (larotrectinib) receives first tumor-agnostic approval in EU Número de registro: 281935 20/09/2019 08:43 BAYER AKTIENGESELLSCHAFT R&D: new licenses, patents and registered trademarks Not intended for U.S. and UK Media - Bayer data at ESMO 2019 highlights innovation in cancer research Número de registro: 281873 10/09/2019 15:17 BAYER AKTIENGESELLSCHAFT Composition of other management and supervisory bodies Bayer reduces size of Board of Management from seven to five members Número de registro: 281626 03/09/2019 08:27 BAYER AKTIENGESELLSCHAFT R&D: new licenses, patents and registered trademarks Xarelto™ 2.5 mg plus aspirin recommended for patients at high risk of heart attacks, strokes and death due to chronic coronary syndromes Número de registro: 281424 02/09/2019 11:27 BAYER AKTIENGESELLSCHAFT Transmissions and purchases of capital undertakings Bayer completes sale of iconic Coppertone™ brand to Beiersdorf Número de registro: 281415 20/08/2019 11:54 BAYER AKTIENGESELLSCHAFT Transmissions and purchases of capital undertakings Bayer to sell its Animal Health business unit to Elanco for 7.6 billion U.S. dollars Número de registro: 281264 08/08/2019 15:27 BAYER AKTIENGESELLSCHAFT Transmissions and purchases of capital undertakings Bayer acquires BlueRock Therapeutics to build leading position in cell therapy Número de registro: 281174 07/08/2019 11:27 BAYER AKTIENGESELLSCHAFT Transmissions and purchases of capital undertakings Bayer and LANXESS to sell their stakes in Currenta to Macquarie Infrastructure and Real Assets Número de registro: 281102 31/07/2019 07:28 BAYER AKTIENGESELLSCHAFT R&D: new licenses, patents and registered trademarks Not intended for U.S. and UK Media - U.S. FDA approves darolutamide, a new treatment for men with non-metastatic castration-resistant prostate cancer Número de registro: 280940 30/07/2019 07:49 BAYER AKTIENGESELLSCHAFT Information on P&L Bayer on track in operational business Número de registro: 280800 Página 2 de 137 «12345...»
